Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations …

…, E Zagórowicz, T Raine, M Harbord… - Journal of Crohn's …, 2017 - academic.oup.com
1.2. Definitions Ulcerative colitis [UC] is a chronic inflammatory condition that causes continuous
mucosal inflammation of the colon, usually without granulomas on biopsy. It affects the …

3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: part 1: diagnosis and medical management

…, M Harbord, J Langhorst, M Sans… - Journal of Crohn's …, 2017 - academic.oup.com
This paper is the first in a series of two publications relating to the European Crohn’s and
Colitis Organisation [ECCO] evidence-based consensus on the diagnosis and management of …

Heritability in inflammatory bowel disease: from the first twin study to genome-wide association studies

…, F Trier Moller, V Andersen, M Harbord - Inflammatory bowel …, 2015 - academic.oup.com
Since Tysk et al's pioneering analysis of the Swedish twin registry, twin and family studies
continue to support a strong genetic basis of the inflammatory bowel diseases. The coefficient …

The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease

M Harbord, V Annese, SR Vavricka… - Journal of Crohn's …, 2016 - academic.oup.com
… Marcus Harbord † … Marcus Harbord, Vito Annese, Stephan R. Vavricka, Matthieu Allez,
Manuel Barreiro-de Acosta, Kirsten Muri Boberg, Johan Burisch, Martine De Vos, Anne-Marie …

[PDF][PDF] Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management

M Harbord, R Eliakim, D Bettenworth… - Journal of Crohn's …, 2017 - academic.oup.com
… In the PURSUIT-M trial, 464 patients showing evidence of response to induction therapy …
Specifically for those patients entering PURSUIT-M receiving corticosteroids, 34.4% of those …

European Crohn's and Colitis Organisation topical review on transitional care in inflammatory bowel disease

…, J Sieczkowska-Golub, M Harbord - Journal of Crohn's …, 2017 - academic.oup.com
Background This European Crohn’s and Colitis Organisation [ECCO] topical review focuses
on the transition of adolescents with inflammatory bowel disease [IBD] from child-centred to …

Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study

…, NM Croft, JME Fell, M Harbord… - The lancet …, 2019 - thelancet.com
Background Anti-TNF drugs are effective treatments for the management of Crohn's disease
but treatment failure is common. We aimed to identify clinical and pharmacokinetic factors …

The spectrum of SCN1A-related infantile epileptic encephalopathies

…, D Gill, K Farrell, M Connolly, T Stanley, M Harbord… - Brain, 2007 - academic.oup.com
The relationship between severe myoclonic epilepsy of infancy (SMEI or Dravet syndrome)
and the related syndrome SMEI-borderland (SMEB) with mutations in the sodium channel …

Defective acute inflammation in Crohn's disease: a clinical investigation

DJB Marks, MWN Harbord, R MacAllister, FZ Rahman… - The Lancet, 2006 - thelancet.com
Background The cause of Crohn's disease has not been mechanistically proven. We tested
the hypothesis that the disease is a form of immunodeficiency caused by impaired innate …

[PDF][PDF] Disruption of the serine/threonine kinase 9 gene causes severe X-linked infantile spasms and mental retardation

…, N Tommerup, H Eyre, M Harbord… - The American Journal of …, 2003 - cell.com
X-linked West syndrome, also called "X-linked infantile spasms" (ISSX), is characterized by
early-onset generalized seizures, hypsarrhythmia, and mental retardation. Recently, we have …